Celgene Corporation (CELG) Tops Q1 EPS by 3c; Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Research and development: 1.65B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 1.65B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Celgene Corporation (NASDAQ: CELG) reported Q1 EPS of $0.83, $0.03 better than the analyst estimate of $0.80. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.08 billion.
Raises its FY11 EPS guidance from $3.30-$3.35 to $3.35-$3.40, versus the consensus of $3.39.
Raises its FY11 EPS guidance from $3.30-$3.35 to $3.35-$3.40, versus the consensus of $3.39.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
